Issued - Wednesday 21 May 2008, London - LSE Announcement
GlaxoSmithKline plc - Results of AGM
GlaxoSmithKline (GSK) announces that at today's Annual General Meeting all resolutions, including those electing and re-electing Board members, were passed by shareholders.
GlaxoSmithKline Annual General Meeting Poll Results
The following table shows the votes cast for each resolution:
Resolution |
Total votes for* |
% |
Total votes against |
% |
Total votes cast |
Votes withheld** |
|
1 |
Adoption of Financial Statements |
3,749,614,298 |
95.18 |
189,859,453 |
4.82 |
3,939,473,751 |
9,410,864 |
2 |
Approval of the Remuneration Report |
2,423,411,670 |
85.89 |
398,271,204 |
14.11 |
2,821,682,874 |
1,127,201,561 |
3 |
Election of Mr Andrew Witty |
3,877,718,934 |
99.23 |
29,969,659 |
0.77 |
3,907,688,593 |
41,195,842 |
4 |
Election of Mr Christopher Viehbacher |
3,849,501,839 |
99.49 |
19,772,868 |
0.51 |
3,869,274,707 |
79,609,728 |
5 |
Election of Professor Sir Roy Anderson |
3,909,528,117 |
99.82 |
7,050,023 |
0.18 |
3,916,578,140 |
32,306,295 |
6 |
Re-election of Sir Christopher Gent |
3,810,072,560 |
98.08 |
74,773,259 |
1.92 |
3,884,845,819 |
64,038,616 |
7 |
Re-election of Sir Ian Prosser |
3,907,565,196 |
99.77 |
9,050,718 |
0.23 |
3,916,615,914 |
32,268,521 |
8 |
Re-election of Dr Ronaldo Schmitz |
3,899,485,674 |
99.56 |
17,139,141 |
0.44 |
3,916,624,815 |
32,259,620 |
9 |
Re-appointment of Auditors |
3,877,708,481 |
99.54 |
17,936,334 |
0.46 |
3,895,644,815 |
53,239,620 |
10 |
Remuneration of Auditors |
3,913,134,400 |
99.69 |
12,121,289 |
0.31 |
3,925,255,689 |
23,628,746 |
11 |
To authorise the company to make donations to Political Organisations & incur Political Expenditure |
3,764,947,848 |
97.09 |
112,911,635 |
2.91 |
3,877,859,483 |
71,024,952 |
12 |
Authority to allot shares |
3,877,961,825 |
98.44 |
61,623,083 |
1.56 |
3,939,584,908 |
9,299,527 |
13 |
Disapplication of pre-emption rights*** |
3,891,091,851 |
98.82 |
46,291,865 |
1.18 |
3,937,383,716 |
11,500,719 |
14 |
Authority for the Company to purchase its own shares*** |
3,871,222,137 |
98.23 |
69,853,695 |
1.77 |
3,941,075,832 |
7,808,603 |
15 |
Adopt new Articles of Association*** |
3,919,473,970 |
99.55 |
17,602,044 |
0.45 |
3,937,076,014 |
11,808,421 |
Notes:
* Includes discretionary votes.
** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
*** Indicates Special Resolutions requiring a 75% majority
The following table provides further relevant information:
|
GlaxoSmithKline's Eighth AGM (2008) |
GlaxoSmithKline's Seventh AGM (2007) |
Issued share capital (excluding Treasury Shares) |
5,352,175,102 |
5,725,158,425 |
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares) |
73.78% |
73.68% |
Total shareholder population |
172,581 |
180,486 |
Total number of proxies lodged |
12,896 |
14,357 |
% of shareholders who lodged proxies |
7.47% |
7.95% |
Number of shareholders, corporate representatives and proxies who attended the AGM |
266 |
276 |
S M Bicknell
Company Secretary
21 May 2008
These results will shortly be available on the Company's website www.gsk.com.
Enquiries: |
UK Media |
Philip Thomson Alice Hunt Gwenan White |
(020) 8047 5502 (020) 8047 5502 (020) 8047 5502 |
|
|
|
|
|
US Media |
Nancy Pekarek Mary Anne Rhyne |
(215) 751 7709 (919) 483 2839 |
|
|
|
|
|
European Analyst / Investor |
David Mawdsley Sally Ferguson Gary Davies |
(020) 8047 5564 (020) 8047 5543 (020) 8047 5503 |
|
|
|
|
|
US Analyst / Investor |
Frank Murdolo Tom Curry |
(215) 751 7002 (215) 751 5419 |